370 related articles for article (PubMed ID: 36365207)
1. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia.
Dias AMM; Courteau A; Bellaye PS; Kohli E; Oudot A; Doulain PE; Petitot C; Walker PM; Decréau R; Collin B
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365207
[TBL] [Abstract][Full Text] [Related]
2. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
[TBL] [Abstract][Full Text] [Related]
3. Thermosensitive/superparamagnetic iron oxide nanoparticle-loaded nanocapsule hydrogels for multiple cancer hyperthermia.
Zhang ZQ; Song SC
Biomaterials; 2016 Nov; 106():13-23. PubMed ID: 27543919
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
6. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering.
Nabavinia M; Beltran-Huarac J
ACS Appl Bio Mater; 2020 Dec; 3(12):8172-8187. PubMed ID: 35019598
[TBL] [Abstract][Full Text] [Related]
7. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment.
Hayashi K; Nakamura M; Sakamoto W; Yogo T; Miki H; Ozaki S; Abe M; Matsumoto T; Ishimura K
Theranostics; 2013; 3(6):366-76. PubMed ID: 23781284
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of CD8
Zhang Y; Gao X; Yan B; Wen N; Lee WSV; Liang XJ; Liu X
ChemMedChem; 2022 Jan; 17(2):e202100656. PubMed ID: 34806311
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion.
Rojas JM; Sanz-Ortega L; Mulens-Arias V; Gutiérrez L; Pérez-Yagüe S; Barber DF
Nanomedicine; 2016 May; 12(4):1127-1138. PubMed ID: 26733263
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era.
Pucci C; Degl'Innocenti A; Belenli Gümüş M; Ciofani G
Biomater Sci; 2022 May; 10(9):2103-2121. PubMed ID: 35316317
[TBL] [Abstract][Full Text] [Related]
14. Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages.
Zhang W; Cao S; Liang S; Tan CH; Luo B; Xu X; Saw PE
Front Bioeng Biotechnol; 2020; 8():537. PubMed ID: 32548111
[TBL] [Abstract][Full Text] [Related]
15. Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy.
Janko C; Ratschker T; Nguyen K; Zschiesche L; Tietze R; Lyer S; Alexiou C
Front Oncol; 2019; 9():59. PubMed ID: 30815389
[TBL] [Abstract][Full Text] [Related]
16. Boosting chemotherapy of bladder cancer cells by ferroptosis using intelligent magnetic targeting nanoparticles.
Cai X; Ruan L; Wang D; Zhang J; Tang J; Guo C; Dou R; Zhou M; Hu Y; Chen J
Colloids Surf B Biointerfaces; 2024 Feb; 234():113664. PubMed ID: 38043504
[TBL] [Abstract][Full Text] [Related]
17. Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia.
Das P; Salvioni L; Malatesta M; Vurro F; Mannucci S; Gerosa M; Antonietta Rizzuto M; Tullio C; Degrassi A; Colombo M; Ferretti AM; Ponti A; Calderan L; Prosperi D
J Colloid Interface Sci; 2020 Nov; 579():186-194. PubMed ID: 32590159
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
19. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
[TBL] [Abstract][Full Text] [Related]
20. Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy.
Chao Y; Chen G; Liang C; Xu J; Dong Z; Han X; Wang C; Liu Z
Nano Lett; 2019 Jul; 19(7):4287-4296. PubMed ID: 31132270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
